VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
votubia
Preclinical
Novartis
1
Indications
0
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Angiomyolipoma
Unknown
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Angiomyolipoma
Preclinical
Unknown
Sources
References
[1]
Open Targets Platform
—
Drug–disease associations for votubia. EMBL-EBI & Wellcome Sanger Institute.
[2]
SEC EDGAR
—
Novartis company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Highest Phase
Preclinical
Company
Novartis
Related News